DEADLINE ALERT for FUV, ACAD, and CCIV: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
15 juin 2021 11h15 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, June 15, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
02 juin 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
13 mai 2021 22h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
05 mai 2021 22h14 HE
|
Bragar Eagel & Squire
NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
DEADLINE ALERT for FUV, EBS, and ACAD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
30 avr. 2021 11h00 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, April 30, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
28 avr. 2021 20h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Beverage, ACADIA, and Vuzix and Encourages Investors to Contact the Firm
13 sept. 2018 18h48 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of National Beverage...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ACADIA, Rockwell Medical, and LogMeIn, and Encourages Investors to Contact the Firm
21 août 2018 13h43 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of ACADIA Pharmaceuticals Inc.,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MabVax, Farmland, and ACADIA, and Encourages Investors to Contact the Firm
01 août 2018 17h46 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of MabVax Therapeutics...
Bragar Eagel & Squire, P.C. is Investigating ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) on Behalf of Stockholders and Encourages Investors to Contact the Firm
09 juil. 2018 18h06 HE
|
Bragar Eagel & Squire
NEW YORK, July 09, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Our investigation concerns whether...